About Web_Admin

This author has not yet filled in any details.
So far Web_Admin has created 9 blog entries.

Cycle Pharmaceuticals’ NITYR® (nitisinone) Tablets Receives Marketing Authorization in Israel

By |2021-05-17T18:52:30+01:00October 19th, 2020|News, Nityr|

Cycle Pharmaceuticals’ Supply Chain update

By |2021-05-17T18:52:31+01:00March 13th, 2020|News, Resource|

Cycle Pharmaceuticals’ NITYR (nitisinone) tablets receives marketing authorization in Chile

By |2021-05-17T18:52:31+01:00November 22nd, 2018|News, Nityr|

Cycle Pharmaceuticals Receives FDA Approval and Launches Ketorolac Tromethamine Injection 30mg/mL in the U.S.

By |2021-05-17T18:52:31+01:00August 29th, 2018|Generics, News|

Cycle Pharmaceuticals Receives FDA Approval for Ketorolac Tromethamine Tablets in the U.S.

By |2021-05-17T18:52:31+01:00August 29th, 2018|Generics, News|

Cycle Pharmaceuticals launches free trial of NITYR in the US and Partners with Cambrooke Therapeutics to Support HT-1 Patients’ dietary needs

By |2021-05-17T18:52:31+01:00November 10th, 2017|News, Nityr|

First recommendation for HT-1 treatment in Quebec by INESSS

By |2021-05-17T18:52:31+01:00June 2nd, 2017|News|

CYCLE Pharmaceuticals, The University of Cambridge and King’s College London Partner to Repurpose PARP Inhibitor Drugs for Vascular Disease

By |2021-05-17T18:52:31+01:00December 19th, 2016|News|

CYCLE Pharmaceuticals Nitisinone Tablets Approved by Health Canada for the Treatment of HT-1

By |2021-05-17T18:52:31+01:00November 8th, 2016|News|
Go to Top